Low Rates of Abx Prophylaxis for Pediatric Sickle Cell

Share this content:
Low Rates of Abx Prophylaxis for Pediatric Sickle Cell
Low Rates of Abx Prophylaxis for Pediatric Sickle Cell

MONDAY, Feb. 5, 2018 (HealthDay News) -- Children with sickle cell anemia (SCA) have low rates of receiving ≥300 days of antibiotic prophylaxis, according to a study published online Feb. 5 in Pediatrics.

Sarah L. Reeves, Ph.D., from the University of Michigan in Ann Arbor, and colleagues calculated the proportion of children with SCA who received ≥300 days of antibiotic prophylaxis. Children aged 3 months to 5 years with SCA were identified from 2005 to 2012 in Florida, Illinois, Louisiana, Michigan, South Carolina, and Texas. Through claims for filled prescriptions, receipt of antibiotics was identified.

Data were included for 2,821 children with 5,014 person-years. The researchers found that 18 percent of children received ≥300 days of antibiotics. There was a correlation for each additional sickle cell disease-related outpatient visit and well-child visit with incrementally increased odds of receiving ≥300 days of antibiotics (odds ratios, 1.01 and 1.08, respectively).

"Despite national recommendations and proven lifesaving benefit, antibiotic prophylaxis rates are low among children with SCA," the authors write. "Numerous health care encounters may offer an opportunity for intervention; in addition, such interventions likely need to include social factors that may affect the ability for a child to receive and adhere to antibiotic prophylaxis."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure

8 More U.S. Communities to Be Assessed for ...

Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

Proposed rule will help consumers better understand what the sunscreens they are buying can actually do

U.S. Agencies Probing Johnson  Johnson Over Asbestos in Talc

U.S. Agencies Probing Johnson & Johnson Over Asbestos ...

Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma

is free, fast, and customized just for you!




Already a member?

Sign In Now »